Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities URGN - UroGen Pharma Ltd.
-953 K
LAST VALUE
-11.09%
2 YEAR CAGR
-0.53%
5 YEAR CAGR
-26.76%
10 YEAR CAGR